The structure of bovine complement component 3 reveals the basis for thioester function

被引:68
作者
Fredslund, Folmer [1 ]
Jenner, Lasse [1 ]
Husted, Use B. [1 ]
Nyborg, Jens [1 ]
Andersen, Gregers Rom [1 ]
Sottrup-Jensen, Lars [1 ]
机构
[1] Aarhus Univ, Dept Biol Mol, DK-8000 Aarhus, Denmark
关键词
immunology; complement; thioester; crystal structure; alpha-macroglobulin;
D O I
10.1016/j.jmb.2006.06.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The third component of complement (C3) is a 190 kDa glycoprotein essential for eliciting the complement response. The protein consists of two polypeptide chains (alpha and beta) held together with a single disulfide bridge. The beta-chain is composed of six MG domains, one of which is shared with the alpha-chain. The disulfide bridge connecting the chains is positioned in the shared MG domain. The at-chain consists of the anaphylatoxin domain, three MG domains, a CUB domain, an alpha(6)/alpha(6)-barrel domain and the C-terminal C345c domain. An internal thioester in the a-chain of C3 (present in C4 but not in C5) is cleaved during complement activation. This mediates covalent attachment of the activated C3b to immune complexes and invading microorganisms, thereby opsonizing the target. We present the structure of bovine C3 determined at 3 A resolution. The structure shows that the ester is buried deeply between the thioester domain, and the properdin binding domain, in agreement with the human structure. This domain interface is broken upon activation, allowing nucleophile access. The structure of bovine C3 clearly demonstrates that the main chain around the thioester undergoes a helical transition upon activation. This rearrangement is proposed to be the basis for the high level of reactivity of the thioester group. A strictly conserved glutamate residue is suggested to function catalytically in thioester proteins. Structure-based design of inhibitors of C3 activation may target a conserved pocket between the alpha-chain and the beta-chain of C3, which appears essential for conformational changes in C3. (c) 2006 Published by Elsevier Ltd.
引用
收藏
页码:115 / 127
页数:13
相关论文
共 45 条
[21]   PEPTIDE MODELS OF PROTEIN METASTABLE BINDING-SITES - COMPETITIVE KINETICS OF ISOMERIZATION AND HYDROLYSIS [J].
KHAN, SA ;
SEKULSKI, JM ;
ERICKSON, BW .
BIOCHEMISTRY, 1986, 25 (18) :5165-5171
[22]   The three-dimensional structure of the human α2-macroglobulin dimer reveals its structural organization in the tetrameric native and chymotrypsin α2-macroglobulin complexes [J].
Kolodziej, SJ ;
Wagenknecht, T ;
Strickland, DK ;
Stoops, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) :28031-28037
[23]   Constitutive expression of a complement-like protein in Toll and JAK gain-of-function mutants of Drosophila [J].
Lagueux, M ;
Perrodou, E ;
Levashina, EA ;
Capovilla, M ;
Hoffmann, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) :11427-11432
[24]   KINETICS OF APPEARANCE OF SULFHYDRYL-GROUPS IN ALPHA-2-MACROGLOBULIN ON REACTION OF THE INHIBITOR WITH AMINES [J].
LARSSON, LJ ;
BJORK, I .
BIOCHEMISTRY, 1984, 23 (12) :2802-2807
[25]  
Law SKA, 1997, PROTEIN SCI, V6, P263
[26]   Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteins [J].
Lin, M ;
Sutherland, R ;
Horsfall, W ;
Totty, N ;
Yeo, E ;
Nayar, R ;
Wu, XF ;
Schuh, AC .
BLOOD, 2002, 99 (05) :1683-1691
[27]   Structural aspects and design of low-molecular-mass complement inhibitors [J].
Morikis, D ;
Lambris, JD .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :1026-1036
[28]   COMPLEMENT [J].
MULLEREBERHARD, HJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 1975, 44 :697-724
[29]   X-ray crystal structure of C3d: A C3 fragment and ligand for complement receptor 2 [J].
Nagar, B ;
Jones, RG ;
Diefenbach, RJ ;
Isenman, DE ;
Rini, JM .
SCIENCE, 1998, 280 (5367) :1277-1281
[30]   RELATION OF A PUTATIVE THIOESTER BOND IN C-3 TO ACTIVATION OF THE ALTERNATIVE PATHWAY AND THE BINDING OF C3B TO BIOLOGICAL TARGETS OF COMPLEMENT [J].
PANGBURN, MK ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (04) :1102-1114